In this article, we will take a look at some of the best large cap stocks under $30 that are currently offering attractive upside potential. On June 2, Fundstrat managing partner and CIO Tom Lee shared his views on market trends, artificial intelligence, crypto, and the broader market outlook during an interview with CNBC. Several macro factors are coming together that could support U.S. economic growth, including the possibility of the economy accelerating towards 4% growth for a mature economy.
He noted that the U.S. is a major exporter of artificial intelligence products and said AI will be an important tool over the next 10 to 15 years. Capital allocation, which is currently tilted more towards private alternatives, is expected to shift towards public markets over time. Lee cited demographic trends, including millennials and Gen Z entering the workforce and beginning to inherit generational wealth, as additional factors relevant to market conditions.
He said that markets could experience volatility between June and October, including a potential drawdown, before a stronger move later in the cycle. With that background, let’s explore our 10 Best Large Cap Stocks Under $30 With Highest Upside Potential.
Source:Pixabay
Our Methodology
To identify relevant stocks for this article, we conducted a sector-agnostic screening of U.S.-listed companies with market capitalizations between $10 billion and $200 billion. Also, we only shortlisted stocks with at least 20% upside potential, according to consensus, as of the June 3 close. Finally, we selected 10 stocks with the highest upside and ranked them in ascending order.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
10. Pinterest Inc. (NYSE:PINS)
Pinterest Inc. (NYSE:PINS) is one of the 10 best large cap stocks under $30 with highest upside potential.
Back on May 5, Oppenheimer increased its target price for Pinterest Inc. (NYSE:PINS) from $24 to $30, while maintaining an Outperform rating on the stock. This adjustment follows the company’s first quarter performance, where topline exceeded both Oppenheimer’s and the broader Street expectations.
On an ex-FX basis, revenue grew 15% year over year, marking an improvement over the 13% growth recorded during the fourth quarter. This increase is attributed to recoveries across large retailers amid elevated performance adoption late in the first quarter. The same retailers experienced the impacts of tariffs during most of 2025, which is expected to be a major hurdle for the rest of the year.
However, for the second quarter, Pinterest expects a 2-point organic slowdown without incorporating the FX effects. Even though the management guidance still remains above Oppenheimer’s and Street expectations, the firm says this gap shows limited confidence in a full recovery. Despite this, the firm’s target price translates into an upside potential of over 39% at the current level.
On May 5, RBC Capital increased the target price for Pinterest Inc. (NYSE:PINS) from $17 to $23, while maintaining a Sector Perform rating on the shares. According to the firm, driven by improved conversion rates, the company posted stronger-than-expected first-quarter results, with earlier challenges from major customers gradually easing late in the quarter.
RBC Capital demands greater confidence in AI-driven improvements for content recommendations before having a more favorable view of the stock.
Pinterest Inc. (NYSE:PINS) is an online visual search and discovery platform that operates globally. It enables creativity by allowing users to share and search for a wide range of ideas covering different topics. This could include fitness, style, recipes, art, and more. It also allows users to engage with advertisers, which is a key revenue source for the business.
9. PG&E Corp. (NYSE:PCG)
PG&E Corp. (NYSE:PCG) is one of the 10 best large cap stocks under $30 with highest upside potential.
As of the June 3 closing, consensus sentiment around PG&E Corp. (NYSE:PCG) was strongly bullish. 10 of the 12 analysts who covered it assigned Buy ratings to the stock, while 2 analysts gave Hold calls. With no Sell ratings, the stock has a median one-year target price of $22.92, which leads to an upside of almost 37% at the current level.
On May 18, ahead of the American Gas Association’s Financial Forum, Truist updated its models for the Power and Utilities sector. In line with that, the firm revised its price target for PG&E Corp (NYSE:PCG) down to $22 from $23, while maintaining a Buy rating on the shares. The revision now leads to an upside of more than 31% for investors.
The firm noted that sector investment and overall growth expectations continue to rise as the market enters the third year of the data center wave. It also highlighted that vertically integrated electric utilities are positioned as clear winners due to their role in building out the infrastructure to serve this specific load growth.
PG&E Corp. (NYSE:PCG) sells electricity and natural gas across the U.S. market. The company uses fossil fuel-fired, fuel cells, photovoltaic, nuclear, and hydroelectric sources to generate electricity. It serves residential, commercial, industrial, and agricultural customers, as well as natural gas-fired electricity generation facilities. The company operates through various interconnected transmission lines.
8. DraftKings Inc. (NASDAQ:DKNG)
DraftKings Inc. (NASDAQ:DKNG) is one of the 10 best large cap stocks under $30 with highest upside potential.
On May 21, following a comprehensive credit card data review of approximately 9 million users, Morgan Stanley updated its stance on the digital gaming sector. Analyst Stephen Grambling stated that the data shows very little transaction overlap between Kalshi and the sports betting giants such as DraftKings Inc. (NASDAQ:DKNG).
The firm believes this separation proves that entering prediction markets will capture new demographics and grow the total addressable market. Additionally, higher deposit frequencies indicate ongoing growth in current markets, running counter to the standard industry maturation narrative.
Consequently, the firm maintained its Overweight ratings on the stock, forecasting room for upside revisions and valuation rerating as the company is well-reputed for introducing proprietary prediction market products.
On May 11, Northland raised its price target on DraftKings Inc. (NASDAQ:DKNG) from $24 to $27 while maintaining a Market Perform rating on the shares.
The firm noted that early traction has yielded promising results, which prompted the upward adjustment in price target. This reflects favorably on the ongoing progress relating to the company’s predictions product plan. But Northland maintains a cautious valuation stance due to material risks tied to the rise of the prediction segment.
DraftKings Inc. (NASDAQ:DKNG) is a digital sports entertainment and gaming business. Through a vertically integrated proprietary technology, it offers online betting, fantasy sports, digital lottery, and other relevant products. It leverages high-volume engagement for cross-selling within many of its product categories.
7. KE Holdings Inc. (NYSE:BEKE)
KE Holdings Inc. (NYSE:BEKE) is one of the 10 best large cap stocks under $30 with highest upside potential.
On May 19, KE Holdings Inc. (NYSE:BEKE) reported its impressive quarter-one consolidated revenues of RMB18.9B ($2.74B), which is substantially above the consensus expectation of RMB18.55B. The company continues to promote efficiency-driven growth, and this financial update follows strong marginal gains in the broader real estate market.
According to CEO Stanley Yongdong Peng, the company is actively prioritizing long-term sustainable development. That is being achieved by optimizing organizational efficiency, advancing AI-enabled capabilities, and assisting customers in selecting better residential options.
CFO Tao Xu pointed out that recent efforts to improve resource allocation, cost structures, and optimization of unit economics are paying off. The company’s profitability measures got a boost as gross margins and adjusted operating margins rose to their highest in seven quarters. These gains led to an adjusted EPS of 20c for the first quarter.
The company has invested over $195 million in repurchasing shares on the open market, a notable 40% increase from the previous year. This was done in order to significantly improve net profitability and overall shareholder returns.
KE Holdings Inc. (NYSE:BEKE) provides an integrated online and offline platform for housing transactions, rentals, renovations, and related services across the Chinese market. The business is structured around 5 segments, i.e., Existing Home Transaction Services, New Home Transaction Services, Home Renovation & Furnishing, Home Rental Services, and Emerging & Other Services.
6. Genmab A/S (NASDAQ:GMAB)
Genmab A/S (NASDAQ:GMAB) is one of the 10 best large cap stocks under $30 with highest upside potential.
On May 27, coverage of Genmab A/S (NASDAQ:GMAB) was resumed by Truist analyst Gregory Renza. The analyst reduced the price target from $48 to $40 and assigned a Buy rating to the stock. He shared an optimistic view about the company following its shift towards a commercially focused business platform. This is backed by three key assets comprising around seven important readouts during 2026.
According to Renza, Rina-S and petosemtamab have the potential to be best- or first-in-class in ovarian cancer and HNSCC, respectively, while Epkinly’s DLBCL-2/-4 results are crucial for franchise expansion.
Back on April 30, H.C. Wainwright reduced the target price on Genmab A/S (NASDAQ:GMAB) from $40 to $38, leading to an adjusted upside potential in excess of 54%. The firm upheld its Buy rating on the shares.
Based on Pfizer’s MagnetisMM-5 trial outcomes, the firm anticipates a strong probability that, among physicians, Elrexfio will be favored over dexamethasone in treating relapsed or refractory multiple myeloma patients who have undergone at least one prior line of therapy.
Genmab A/S (NASDAQ:GMAB) is a biotechnology company based in Denmark that is engaged in developing antibodies and related products to cure cancer and other diseases. The company markets various cures for adults, including EPKINLY, TEPKINLY, and Tivdak.
While we acknowledge the potential of GMAB to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than GMAB and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Best Large Cap Stocks Under $30 With Highest Upside Potential.
Disclosure: None. Follow Insider Monkey on Google News.
